Why the study?
Patients with cancer and cardiovascular disease are particularly vulnerable during the COVID-19 pandemic, requiring evaluation of the pandemic's impact to optimize medical strategies during and after the emergency.
Population
Cardio-oncologic patients during the COVID-19 pandemic
Design
Position paper
Authors
Loading...
Prioritizes protection for cancer/CVD patients in pandemics; confirms their heightened risks and health-system disruptions.
This position paper outlines strategic adjustments, including telemedicine and targeted imaging, to maintain cardio-oncology care standards while minimizing COVID-19 infection risks.
Bisceglia et al. (2021) conducted a review in Cancer and cardiovascular disease during COVID-19. Cardio-oncology care adaptations (telemedicine, biomarkers, targeted imaging) was evaluated. The COVID-19 pandemic requires rapid adaptation of cardio-oncology care pathways, utilizing telemedicine, biomarkers, and targeted imaging to maintain care standards and minimize infection risk.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: